Studies from Novo Nordisk due early next month will give the strongest indication yet of whether blockbuster GLP-1 drugs - a ...

A new study has identified three existing medications that could be repurposed to treat or prevent Alzheimer's disease.

Alzheimer’s disease impacts tens of millions of families throughout the world, and projections state that more than 100 ...

Novo Nordisk will soon announce the results of perhaps the most ambitious studies yet of its GLP-1 drug: whether it can help ...

In a new study, scientists discovered two FDA-approved cancer drugs that could also be effective at combatting one well-known ...

Novo Nordisk is expected to announce soon whether its blockbuster GLP-1 drug semaglutide can help slow Alzheimer’s disease ...

The review synthesizes evidence on whether Alzheimer’s disease medications can improve neurocognitive outcomes in children ...

A new study shows that lecanemab, an amyloid-clearing Alzheimer’s therapy, does not improve the brain’s waste-removal network ...

A FREE NHS jab could be the most promising drug yet to stop Alzheimer’s, experts say. Two other medicines, to treat erectile dysfunction and motor neurone disease, also showed strong potential.

Study found drugs used to prevent shingles and treat erectile dysfunction could be promising for Alzheimer’s patients ...

Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering ...